60 DEGREES PHARMACEUTICALS, INC. - 10-Q Filing

60 Degrees Pharmaceuticals reports Q3 2026 financial results including updates on warrants, preferred stock, and contingent milestone payments.

SEC EDGAR ·

Tickers: $SXTP

Read the full article at SEC EDGAR

More Regulatory news